SEARCH

SEARCH BY CITATION

References

  • Abdel-Malak, N.A., Srikant, C.B., Kristof, A.S., Magder, S.A., Di Battista, J.A. & Hussain, S.N. (2008) Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8. Blood, 111, 41454154.
  • Attygalle, A., Al Jehani, R., Diss, T.C., Munson, P., Liu, H., Du, M.Q., Isaacson, P.G. & Dogan, A. (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood, 99, 627633.
  • Baseggio, L., Berger, F., Morel, D., Delfau-Larue, M.H., Goedert, G., Salles, G., Magaud, J.P. & Felman, P. (2006) Identification of circulating CD10 positive T cells in angioimmunoblastic T-cell lymphoma. Leukemia, 20, 296303.
  • Bazarbachi, A., Ghez, D., Lepelletier, Y., Nasr, R., De Thé, H., El-Sabban, M.E. & Hermine, O. (2004) New therapeutic approaches for adult T-cell leukaemia. The Lancet Oncology, 5, 664672.
  • Bellamy, W.T., Richter, L., Frutiger, Y. & Grogan, T.M. (1999) Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Research, 59, 728733.
  • Bertolini, F., Mancuso, P., Gobbi, A. & Pruneri, G. (2000) The thin red line: angiogenesis in normal and malignant hematopoyesis. Experimental Hematology, 28, 9931000.
  • Bujanda, D.A. (2008) Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab. Annals of Oncology, 19, 396397.
  • Carmeliet, P. (2003) Angiogenesis in health and disease. Nature Medicine, 9, 653660.
  • Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature, 438, 932936.
  • Di Carlo, E., D’Antuono, T., Contento, S., Di Nicola, M., Ballone, E. & Sorrentino, C. (2007) Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections. American Journal of Transplantation, 7, 201210.
  • Dogan, A., Ngu, L.S., Ng, S.H. & Cervi, P.L. (2005) Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia, 19, 873875.
  • Dunleavy, K., Wilson, W.H. & Jaffe, E.S. (2007) Angioimmunoblastic T-cell lymphoma: pathological insights and clinical implications. Current Opinion in Haematology, 14, 348353.
  • Elliott, R.L. & Blobe, G.C. (2005) Role of transforming growth factor beta in human cancer. Journal of Clinical Oncology, 23, 20782093.
  • Ferrara, N., Gerber, H.P. & LeCouter, J. (2003) The biology of VEGF and its receptors. Nature Medicine, 9, 669676.
  • Ferry, J.A. (2002) Angioimmunoblastic T-cell lymphoma. Advances in Anatomic Pathology, 9, 273279.
  • Foss, H.D., Araujo, I., Demel, G., Klotzbach, H., Hummel, M. & Stein, H. (1997) Expression of vascular endothelial growth factor in lymphomas and Castleman’s disease. Journal of Pathology, 183, 4450.
  • Fukushima, N., Satoh, T., Sano, M. & Tokunaga, O. (2001) Angiogenesis and mast cells in non-Hodgkin’s lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma. Leukemia & Lymphoma, 42, 709722.
  • Harfouche, R. & Hussain, S.N. (2006) Signalling and regulation of endothelial cell survival by angiopoietin-2. Americal Journal of Physiology. Heart and Circulatory Physiology, 291, H1635H1645.
  • Hlatky, L., Hahnfeldt, P. & Folkman, J. (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. Journal of the National Cancer Institute, 94, 883893.
  • Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. IARC Press, Lyon.
  • Jorgensen, J.M., Sorensen, F.B., Bendix, K., Nielsen, J.L., Olsen, M.L., Funder, A.M.D. & D’amore, F. (2007) Angiogenesis in non-Hodgkin’s lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes. Leukemia and Lymphoma, 48, 584595.
  • Keith, T., Araki, Y., Ohyagi, M., Hasegawa, M., Yamamoto, K., Kurata, M., Nakagawa, Y., Suzuki, K. & Kitagawa, M. (2007) Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia. British Journal of Haematology, 137, 206215.
  • Kodama, J., Seki, N., Tokumo, K., Hongo, A., Miyagi, Y., Yoshinouchi, M., Okuda, H. & Kudo, T. (1999) Platelet-derived endotelial cell growth factor is not implicated in progresión of cervical cancer. Oncology Reports, 6, 617620.
  • De Leval, L., Savilo, E., Longtine, J., Ferry, J.A. & Harris, N.L. (2001) Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. American Journal of Surgical Pathology, 25, 395400.
  • De Leval, L., Rickman, D.S., Thielen, C., De Reynies, A., Huang, Y.-L., Delsol, G., Lamant, L., Leroy, K., Briere, J., Molina, T., Berger, F., Gisselbrecht, C., Xerri, L. & Gaulard, P. (2007) The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AILT) and follicular helper T (TFH) cells. Blood, 109, 49524963.
  • Lim, S.T. & Levine, A.M. (2005) Angiogenesis and hematological malignancies. Hematology, 10, 1124.
  • Livak, K.J. & Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods, 25, 402408.
  • Makinde, T. & Agrawal, D.K. (2008) Intra and extra-vascular trans-membrane signalling of angiopoietin-1-Tie2 receptor in health and disease. Journal of Cellular and Molecular Medicine, 12, 810828.
  • Mangi, M.H. & Newland, A. (2000) Angiogenesis and angiogenic mediators in haematological malignancies. British Journal of Haematology, 111, 4351.
  • Merchant, S.H., Amin, M.B. & Viswanatha, D.S. (2006) Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma: emphasis on phenotypic aberrancies for early diagnosis. American Journal of Clinical Pathology, 126, 2938.
  • Moehler, T.M., Ho, A.D., Goldschmidt, H. & Barlogie, B. (2003) Angiogenesis in hematologic malignancies. Critical Reviews in Oncology/Hematology, 45, 227244.
  • Piccaluga, P.P., Agostinelli, C., Califano, A., Carbone, A., Fantoni, L., Ferrari, S., Gazzola, A., Gloghini, A., Righi, S., Rossi, M., Tagliafico, E., Zinzani, P.L., Zupo, S., Baccarani, M. & Pileri, S.A. (2007) Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Research, 67, 1070310710.
  • Ramasamy, K., Lim, Z.Y., Pagliuca, A., Salisbury, J.R., Mufti, G.J. & Devereux, S. (2006) Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone. Haematologica, 91, 117118.
  • Ribatti, D., Vacca, A. & Dammacco, F. (1999) The role of vascular phase in solid tumour growth: a historical review. Neoplasia, 1, 293302.
  • Ribatti, D., Nico, B., Crivellato, E., Roccaro, A.M. & Vacca, A. (2007a) The history of the angiogenic switch concept. Leukemia, 21, 4452.
  • Ribatti, D., Vacca, A., Rusnati, M. & Presta, M. (2007b) The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. Cytokine and Growth Factor Reviews, 18, 327334.
  • Strupp, M., Aivado, U., Germing, N. & Gattermann, R. (2003) Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports. Leukemia and Lymphoma, 43, 133137.
  • Terris, B., Scoazec, J.Y., Rubbia, L., Bregeaud, L., Pepper, M.S., Ruszniewski, P., Belghiti, J., Flejou, J. & Degott, C. (1998) Expression of vascular endothelial growth factor in digestive neuroendocrine tumours. Histopathology, 32, 233238.
  • Tjin, E.P., Bende, R.J., Derksen, P.W., Van Huijstee, A.P., Kataoka, H., Spaargaren, M. & Pals, S.T. (2005) Follicular dendritic cells catalyze hepatocyte growth factor (HGF) activation in the germinal center microenvironment by secreting the serine protease HGF activator. Journal of Immunology, 175, 28072813.
  • Yamamoto, K., Abe, S., Nakagawa, Y., Suzuki, K., Hasegawa, M., Inoue, M., Kurata, M., Hirokawa, K. & Kitagawa, M. (2004) Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia. Leukemia Research, 28, 12031211.
  • Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J. & Holash, J. (2000) Vascular-specific growth factors and blood vessel formation. Nature, 407, 242248.
  • Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H. & Kuwano, M. (1997) Involvement of interleukin-8, vascular endothelial growth factor and basic fibroblast growth factor in tumour necrosis factor alpha-dependent angiogenesis. Molecular and Cellular Biology, 17, 40154023.
  • Zhang, Y.W., Su, Y., Volpert, O.V. & Vande Woude, G.F. (2003) Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proceedings of the National Academy of Sciences of the United States of America, 100, 1271812723.
  • Zhao, W.-L., Mourah, S., Mounier, N., Leboeuf, C., Daneshpouy, M.E., Legres, L., Meignin, V., Oksenhendler, E., Le Maignin, C., Calvo, F., Briere, J., Gisselbrecht, C. & Janin, A. (2004) Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Laboratory Investigation, 84, 15121519.